Carvolix

🗓 Founded 2026👥 50 employees💰 Last funded Apr 2026
Medical Equipment Manufacturing
LinkedIn
Carvolix is a French medical technologies company, commercial and clinical stage, founded by Truffle Capital, that aims to become a global leader in the treatment of structural heart diseases and strokes, worlds leading causes of mortality and disability. Carvolix develops novel AI and imaging driven mini-robots that make complex procedures doble by interventional cardiologists, as well as biomimetics heart valves.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2026
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Carvolix?
Carvolix has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Carvolix last raise funding?
The most recent investment in Carvolix recorded on gritt.io was in April 2026.
When was Carvolix founded?
Carvolix was founded in 2026.
What industry is Carvolix in?
Carvolix operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.